MorganRosel Wealth Management’s Chemours CC Stock Holding History

MorganRosel Wealth Management’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-64	Closed	-$866	–	362
2025 Q1	$866	Buy	+64	New	+$1.06K	﹤0.01%	324

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

AWAM

Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MorganRosel Wealth Management's CC Position: Q2 2025 in Review

MorganRosel Wealth Management sold out of Chemours (CC) in Q2 2025, closing a stake of 64 shares — an estimated $866 sold.

MorganRosel Wealth Management first reported a position in CC in Q1 2025 and held it in 1 quarter. The position peaked at $866 in Q1 2025. 434 funds tracked by Wall St. Rank hold CC as of Q2 2025.

MorganRosel Wealth Management reported no remaining Chemours position as of Q2 2025 after selling out during the quarter.
MorganRosel Wealth Management sold 64 Chemours shares in Q2 2025, an estimated $866.
MorganRosel Wealth Management first reported a position in Chemours in Q1 2025 and held it in 1 quarter.
MorganRosel Wealth Management's Chemours position peaked at $866 in Q1 2025.
434 funds tracked by Wall St. Rank held Chemours as of Q2 2025.

Based on MorganRosel Wealth Management's 13F filing for Q2 2025, filed 1 Aug 2025.